The Correlation Between Individualized Brain Metabolic Networks Based on 18 F-FDG PET/CT and Cognitive Function Changes in DLBCL Patients Before and After Chemotherapy (EANM 2026) - Sep 29, 2026 - Abstract #EP-0733; "Aim/Introduction: R-CHOP is the standard regimen for non-Hodgkin lymphoma and may induce chemotherapy-related cognitive impairment (CRCI), with deficits in memory, attention, information processing speed, and executive function... Patients with DLBCL exhibit pre-existing local nodal abnormalities in brain networks, which are further exacerbated after chemotherapy and closely associated with dynamic cognitive decline. Longitudinal analysis of individualized brain metabolic networks based on ¹⁸F-FDG PET/CT may serve as a potential imaging biomarker for CRCI."
Clinical • FDG PET • Alzheimer's Disease • B Cell Lymphoma • Cognitive Disorders • Diffuse Large B Cell Lymphoma • Hematological Malignancies • Lymphoma • Non-Hodgkin's Lymphoma • Solid Tumor
|